Lataa...
Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
Ovarian cancer is a highly deadly malignancy in which recurrence is considered incurable. Resistance to platinum-based chemotherapy bodes a particularly abysmal prognosis, underscoring the need for novel therapeutic agents and strategies. The use of mithramycin, an antineoplastic antibiotic, has bee...
Tallennettuna:
| Julkaisussa: | Biomedicines |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7828137/ https://ncbi.nlm.nih.gov/pubmed/33445667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9010070 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|